TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
NKTX

Nkarta Inc

Healthcare · Biotechnology

2.90$ +3.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Nkarta Inc (NKTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 404 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NKTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
9.6 48 338 274 473 379 501 404
8.2 37 319 246 361 253 273 283
7.9 21 97 61 37 31 28 40
7.9 37 315 238 352 248 267 276
0.2 – – – 1.3 0.2 0.2 2.0
0.1 – – – -4.2 – – –
1.3 10 18 13 62 – – –
15 74 16 23 101 106 93 92
2.1 8.2 8.8 13 22 23 19 22
– 1.5 1.4 2.5 4.2 6.1 6.1 6.9
0.4 1.9 1.2 1.1 1.8 3.7 0.6 2.1
-5.4 -25 321 251 372 273 408 312
-5.6 -27 -118 -204 -318 -435 -544 -648
50 9.0 32 33 44 49 68 74

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?